Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason R Burchett

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Substance Use & Misuse|July 30, 2021
Impulsivity and Medical Care Utilization in Veterans Treated for Substance Use DisorderJames M Bjork, Jarrod Reisweber, Jason R Burchett, et al.
Cells|October 14, 2022
Targeting Mast Cells in Allergic Disease: Current Therapies and Drug RepurposingJason R Burchett, Jordan M Dailey, Sydney A Kee, et al.
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies|January 26, 2018
Genetic and Environmental Contributions of Negative Valence Systems to Internalizing PathwaysJennifer L Cecilione, Lance M Rappaport, Shannon E Hahn, et al.
Frontiers in Immunology|December 29, 2025
IL-33-mediated mast cell and eosinophil function requires isoprenylationJason R Burchett, Aditya Kotha, Destiny T Davis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2024
IL-33 Induces Cellular and Exosomal miR-146a Expression as a Feedback Inhibitor of Mast Cell FunctionMarcela T Taruselli, Amina Abdul Qayum, Daniel Abebayehu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 14, 2023
Inhibiting Isoprenylation Suppresses FcεRI-Mediated Mast Cell Function and Allergic InflammationJordan M Dailey, Sydney A Kee, Anuj Tharakan, et al.
Cellular Immunology|December 9, 2021
Fluvastatin enhances IL-33-mediated mast cell IL-6 and TNF productionMarcela T Taruselli, Elizabeth Motunrayo Kolawole, Amina Abdul Qayum, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Substance Use & Misuse|July 30, 2021
Impulsivity and Medical Care Utilization in Veterans Treated for Substance Use DisorderJames M Bjork, Jarrod Reisweber, Jason R Burchett, et al.
Cells|October 14, 2022
Targeting Mast Cells in Allergic Disease: Current Therapies and Drug RepurposingJason R Burchett, Jordan M Dailey, Sydney A Kee, et al.
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies|January 26, 2018
Genetic and Environmental Contributions of Negative Valence Systems to Internalizing PathwaysJennifer L Cecilione, Lance M Rappaport, Shannon E Hahn, et al.
Frontiers in Immunology|December 29, 2025
IL-33-mediated mast cell and eosinophil function requires isoprenylationJason R Burchett, Aditya Kotha, Destiny T Davis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2024
IL-33 Induces Cellular and Exosomal miR-146a Expression as a Feedback Inhibitor of Mast Cell FunctionMarcela T Taruselli, Amina Abdul Qayum, Daniel Abebayehu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 14, 2023
Inhibiting Isoprenylation Suppresses FcεRI-Mediated Mast Cell Function and Allergic InflammationJordan M Dailey, Sydney A Kee, Anuj Tharakan, et al.
Cellular Immunology|December 9, 2021
Fluvastatin enhances IL-33-mediated mast cell IL-6 and TNF productionMarcela T Taruselli, Elizabeth Motunrayo Kolawole, Amina Abdul Qayum, et al.
Pageof 1